Smartlink Partners
VC Fund
Warsaw, Poland
Smartlink Partners is a venture capital fund that invests in early-stage software startups.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 53%
Last updated:
For AI agents: llms.txt
Industries Smartlink Partners invests in
Stages Smartlink Partners invests in
Countries Smartlink Partners invests in
Round sizes
Round size
- Seed
- $188k–$4.8M
- Series A
- $2.7M–$14M
Investment Focus
Industry
- Health Care 4 (24%)
- Software 3 (18%)
- Medical Device 3 (18%)
- SaaS 2 (12%)
- Medical 2 (12%)
Stage
- Seed 9 (53%)
- Series A 3 (18%)
- Venture - Series Unknown 2 (12%)
- Funding Round 1 (6%)
- Convertible Note 1 (6%)
Country
- Poland 8 (47%)
- United Kingdom 2 (12%)
- Canada 1 (6%)
- United States 1 (6%)
- Czech Republic 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Choice is B2B SaaS for the restaurants, that offers an online solution for direct ordering, marketplace operations management, table reservation and guest engagement, all on a single platform. We collect all customer data for restaurants, helping them to understand customer behaviour and communicate effectively online.Choice's mission is tobring modern technologies to restaurants and educate owners on how to increase profits with their help. Our goal is to cover all the channels restaurants need to communicate with their customers online into one platform, provide customers with advanced insights and increase guest retention. | $6.9M / Series A / Mar 16, 2026 | ||
| WearLinq is a provider of wearable health monitoring and diagnosis solutions. The company's device records a multi-lead ECG and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, aFib, bradycardia, and tachycardia, allowing users to discover history and trends, set reminders, andconnect directly with physicians. | $14M / Series A / Dec 17, 2025 | ||
| Doctor.One is a chronic care platform that empowers healthcare professionals to stay connected with their patients through continuous, asynchronous communication. By transforming care into a relationship-driven experience beyond the visit, we help improve engagement, boost adherence, and ensure that no chronic patient feels alone in their healthjourney. | $4.7M / Seed / Sep 17, 2025 | ||
| ReSpo.Vision uses artificial intelligence to revolutionize football. It uses AI research to watch and analyze football games, providing unrivaled depth of knowledge to players, scouts, managers, clubs, and federations. | $4.8M / Seed / Jun 10, 2025 | ||
| Founded by scientists specialised in Nanotechnology, Medicinal Chemistry and Artificial Intelligence, we are on a mission to enable early detection of cancer through a rapid and affordable blood test Backed by academics at top universities, clinicians, industrial leaders, and Entrepreneur First. | $1.4M / Venture - Series Unknown / Apr 10, 2025 | ||
| Choice is B2B SaaS for the restaurants, that offers an online solution for direct ordering, marketplace operations management, table reservation and guest engagement, all on a single platform. We collect all customer data for restaurants, helping them to understand customer behaviour and communicate effectively online.Choice's mission is tobring modern technologies to restaurants and educate owners on how to increase profits with their help. Our goal is to cover all the channels restaurants need to communicate with their customers online into one platform, provide customers with advanced insights and increase guest retention. | $1M / Convertible Note / Mar 03, 2025 | ||
| CampusAI turns online learning into an authentic journey. It is a generative platform to design and build a system that instructs users in the ethical and professional use of artificial intelligence. CampusAI collaborates with reputable experts in both science and business. CampusAI was given access to CampusAI's research findings, expertise,and even their image. CampusAI created digital representations of people and organized their knowledge into a digital environment that is accessible to anyone. | $757.3K / Seed / Feb 24, 2025 | ||
| Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $4.6M / Seed / Jan 20, 2025 | ||
| WearLinq is a provider of wearable health monitoring and diagnosis solutions. The company's device records a multi-lead ECG and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, aFib, bradycardia, and tachycardia, allowing users to discover history and trends, set reminders, andconnect directly with physicians. | $700K / Seed / Oct 26, 2024 | ||
| As BioCam.ai, we want to popularize capsule endoscopy as a patient-friendly remote examination of the entire gastrointestinal tract supported by AI algorithms and implement on the market a new standard of gastrointestinal screening for humans and animals. | $188K / Seed / Aug 09, 2024 | ||
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Smartlink Partners invest in?
Smartlink Partners invests primarily in Health Care, Software and Medical Device startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Smartlink Partners's check size?
Smartlink Partners typically joins rounds of $188k–$4.8M at Seed and $2.7M–$14M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Smartlink Partners participates in.
When did Smartlink Partners last invest?
The most recent investment recorded for Smartlink Partners closed in Mar 2026. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
